Status:
COMPLETED
Polycystic Ovary Syndrome and Liraglutide
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
PCOS
Obesity
Eligibility:
FEMALE
18-55 years
Phase:
PHASE4
Brief Summary
The purpose of this study was to determine whether liraglutide is more effective than metformin in the treatment of obese women with newly diagnosed polycystic ovary syndrome (PCOS). We anticipated gr...
Eligibility Criteria
Inclusion
- 18 years old to menopause
- polycystic ovary syndrome (NICHD criteria)
- BMI of 30 kg/m² or higher
Exclusion
- type 1 or type 2 diabetes mellitus
- history of carcinoma
- Cushing's syndrome or congenital (non-classic) adrenal hyperplasia
- personal or family history of MEN 2
- significant cardiovascular, kidney or hepatic disease
- the use of medications known or suspected to affect reproductive or metabolic functions
- the use of statins, within 90 days prior to study entry
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT01899430
Start Date
November 1 2011
End Date
April 1 2013
Last Update
July 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Ljubljana
Ljubljana, Slovenia, 1000